Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investing is vital for financial growth, allowing your money to work for you. Explore the benefits of starting your investment journey.
27,154 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A 70/30 portfolio looks conservative on paper, but the 2022 stress test exposes a $187,000 shortfall on a $2.1 millio...
Bland, a San Francisco voice AI startup, raised $50 million in a Series C led by Dell Technologies Capital, defying d...
OpenAI’s CFO unveils a four-question framework to assess whether AI spending actually delivers value. The approach fo...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...
Ripple vaults onto CNBC’s disruptor list, while XRP trades in a tight range. The token hovered around $1.35 as market...
Want to boost your income without quitting your day job? This guide reviews the best apps for making extra money, exp...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
Retirees with large traditional 401(K) balances face sizable required minimum distributions starting at age 73. The f...
A 22-year-old founder, backed by Lux Capital, is raising $30 million to launch American Perpetuals Exchange Corporati...
January data shows the fed's favored inflation gauge staying elevated, underscoring persistent price pressures as pol...
A growing set of workers with W-2 income are layering a SOLO 401(K) on top of their employer plans to juice retiremen...